MAP3K1 and cancer: The significantly mutated cancer genes (q-value = <0.1) presented in more than 5% of HM individuals are PIK3CA (28%), TP53 (20%), AKT (8%), and MAP3K1 (5%) (Fig. 4a) (Supplementary Data 5).